VYGR Voyager Therapeutics, Inc.

Fundamentals / CIK 0001640266 / USD

Voyager Therapeutics, Inc. reported $25.11M in revenue and a net loss of $104.5M for the trailing twelve months ended September 30, 2026 (down 70.0% year over year), with a -450.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VYGR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$259.1M$129.5M$0-$133.2MFY 2016 Revenue: $14.22MFY 2016 Net Income: -$40.19M2016FY 2017 Revenue: $10.13MFY 2017 Net Income: -$70.70M2017FY 2018 Revenue: $7.62MFY 2018 Net Income: -$88.29M2018FY 2019 Revenue: $104.4MFY 2019 Net Income: -$43.60M2019FY 2020 Revenue: $171.1MFY 2020 Net Income: $36.74M2020FY 2021 Revenue: $37.41MFY 2021 Net Income: -$71.20M2021FY 2022 Revenue: $40.91MFY 2022 Net Income: -$46.41M2022FY 2023 Revenue: $250.0MFY 2023 Net Income: $132.3M2023FY 2024 Revenue: $80.00MFY 2024 Net Income: -$65.00M2024FY 2025 Revenue: $40.37MFY 2025 Net Income: -$119.7M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $40.37M $80.00M $250.0M $40.91M $37.41M $171.1M $104.4M $7.62M $10.13M $14.22M
Research & Development $134.7M $127.4M $92.17M $60.76M $73.79M $108.8M $119.7M $64.91M $62.26M $42.25M
Total Operating Expenses $172.2M $163.3M $128.0M $91.74M $111.0M $143.7M $156.1M $98.71M $82.00M $55.52M
Operating Income -$131.8M -$83.29M $122.0M -$50.84M -$73.62M $27.38M -$51.68M -$91.09M -$71.86M -$41.30M
EBITDA -$127.8M -$78.56M $126.5M -$44.65M -$68.45M $31.20M -$48.91M -$88.98M -$70.27M -$40.69M
Income Before Tax -$119.6M -$64.34M $133.7M -$46.39M -$71.20M $36.74M -$43.60M -$88.47M -$70.70M -$40.14M
Income Tax Expense $144K $665K $1.41M $16K -- -- -- -$180K -- $52K
Net Income -$119.7M -$65.00M $132.3M -$46.41M -$71.20M $36.74M -$43.60M -$88.29M -$70.70M -$40.19M
Basic EPS -$2.04 -$1.13 $3.08 -$1.21 -$1.89 $0.99 -$1.21 -$2.75 -$2.64 -$1.59
Diluted EPS -$2.04 -$1.13 $2.97 -$1.21 -$1.89 $0.98 -$1.21 -$2.75 -$2.64 -$1.59
Basic Shares Outstanding 58.7M 57.7M 43.0M 38.4M 37.7M 37.1M 35.9M 32.1M 26.8M 25.3M
Diluted Shares Outstanding 58.7M 57.7M 44.6M 38.4M 37.7M 37.3M 35.9M 32.1M 26.8M 25.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $4.01M $3.17M $2.59M $15.34M $13.37M $5.20M $6.47M $6.28M
Research & Development $24.37M $22.04M $24.60M $35.95M $35.87M $31.33M $31.53M $35.58M
Total Operating Expenses $30.44M $29.56M $32.86M $45.27M $43.96M $41.83M $41.17M $44.58M
Operating Income -$26.42M -$26.39M -$30.27M -$29.93M -$30.59M -$36.62M -$34.69M -$38.30M
EBITDA -$25.59M -$25.48M -$29.34M -$28.88M -$29.66M -$35.56M -$33.68M -$37.29M
Income Before Tax -$24.68M -$24.45M -$27.92M -$27.42M -$27.81M -$33.37M -$30.98M -$33.90M
Income Tax Expense $18K $20K $14K $9.0K $83K $15K $37K $584K
Net Income -$24.69M -$24.47M -$27.94M -$27.43M -$27.89M -$33.38M -$31.02M -$34.49M
Basic EPS -$0.40 -$0.40 -$0.47 -- -$0.47 -$0.57 -$0.53 --
Diluted EPS -$0.40 -$0.40 -$0.47 -- -$0.47 -$0.57 -$0.53 --
Basic Shares Outstanding 61.8M 60.5M 59.5M -- 58.8M 58.7M 58.3M --
Diluted Shares Outstanding 61.8M 60.5M 59.5M -- 58.8M 58.7M 58.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $65.30M $71.37M $68.80M $98.96M $117.4M $104.4M $86.04M $46.86M $31.53M $36.64M
Short-Term Investments $131.1M $195.3M $162.1M $19.89M $15.11M $76.70M $195.5M $108.9M $137.5M $137.8M
Cash & Short-Term Investments $201.7M $332.4M $230.9M $118.8M $132.5M $181.1M $281.5M $155.8M $169.1M $174.4M
Accounts Receivable, Net $1.76M $1.50M $80.15M -- -- -- -- -- -- --
Other Current Assets $2.28M $2.87M $2.63M $4.23M $1.70M $1.57M $1.40M $1.36M $766K $1.96M
Total Current Assets $202.7M $276.8M $319.7M $124.5M $136.7M $197.8M $304.7M $162.5M $171.8M $178.8M
Property, Plant & Equipment, Net $13.14M $14.31M $16.49M $17.86M $21.92M $25.43M $17.99M $12.77M $10.28M $7.89M
Long-Term Investments $5.24M $65.70M -- -- -- -- $1.92M $628K $1.10M $1.36M
Total Non-Current Assets $49.59M $116.2M $31.60M $34.86M $57.16M $63.81M $50.10M $14.55M $12.69M $10.78M
Total Assets $252.3M $393.1M $351.3M $159.4M $193.9M $261.6M $354.8M $177.0M $184.5M $189.6M
Accounts Payable $5.01M $4.00M $1.60M $2.57M $574K $634K $4.07M $1.04M $1.02M $550K
Deferred Revenue (Current) $1.59M $24.39M $42.88M $59.38M $33.89M $7.73M $47.23M $20.85M $3.38M $6.76M
Other Current Liabilities -- $7.23M $3.20M $2.83M $5.57M $4.20M $3.19M -- -- --
Total Current Liabilities $26.54M $49.79M $64.51M $72.59M $50.98M $26.77M $76.01M $31.67M $15.90M $13.80M
Deferred Revenue (Non-Current) -- $6.00M $32.36M $6.45M $8.21M $36.09M $147.3M $92.20M $28.18M $34.82M
Other Non-Current Liabilities -- $37.50M $18.09M $21.30M $39.61M $44.41M $31.98M $6.71M $1.01M $25K
Total Non-Current Liabilities $29.66M $43.50M $50.45M $27.75M $47.82M $80.50M $179.2M $98.91M $34.53M $39.84M
Total Liabilities $56.20M $93.29M $115.0M $100.3M $98.80M $107.3M $255.2M $130.6M $50.43M $53.64M
Total Debt (incl. Leases) $36.50M $43.73M $20.29M $23.13M $44.18M $47.61M $34.17M -- -- --
Common Stock $59K $55K $44K $38K $38K $37K $37K $32K $32K $26K
Retained Earnings -$445.9M -$326.2M -$261.2M -$393.5M -$347.1M -$275.9M -$312.6M -$269.1M -$160.7M -$90.02M
Accumulated Other Comp. Income $32K -$407K -$48K -$219K -$138K -$134K -$104K -$133K -$287K -$52K
Total Stockholders' Equity $196.1M $299.8M $236.3M $59.02M $95.06M $154.3M $99.51M $46.45M $134.1M $135.9M
Total Equity $196.1M $299.8M $236.3M $59.02M $95.06M $154.3M $99.51M $46.45M $134.1M $135.9M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $48.41M $35.77M $43.31M $65.30M $45.12M $43.94M $74.75M $71.37M
Short-Term Investments $58.40M $80.57M $98.17M $131.1M $163.8M $171.7M $161.3M $195.3M
Cash & Short-Term Investments $132.1M $148.8M $171.7M $201.7M $229.0M $262.0M $295.1M $332.4M
Accounts Receivable, Net $4.02M $2.93M $1.49M $1.76M $3.19M $1.67M $1.62M $1.50M
Other Current Assets -- -- -- $2.28M -- -- -- $2.87M
Total Current Assets $114.4M $125.2M $147.0M $202.7M $219.6M $227.9M $245.2M $276.8M
Property, Plant & Equipment, Net $9.77M $11.19M $12.22M $13.14M $13.29M $13.92M $13.93M $14.31M
Long-Term Investments $25.33M $32.48M $30.18M $5.24M $20.08M $46.45M $59.10M $65.70M
Other Non-Current Assets $214K $214K -- -- -- -- -- --
Total Non-Current Assets $62.62M $72.53M $72.34M $49.59M $68.73M $94.21M $108.0M $116.2M
Total Assets $177.1M $197.8M $219.3M $252.3M $288.3M $322.1M $353.2M $393.1M
Accounts Payable $1.95M $1.61M $2.72M $5.01M $2.12M $1.80M $2.63M $4.00M
Deferred Revenue (Current) $0 $244K $395K $1.59M $10.58M $20.52M $21.09M $24.39M
Other Current Liabilities -- -- -- -- -- -- -- $7.23M
Total Current Liabilities $16.81M $16.68M $17.45M $26.54M $35.49M $41.98M $40.21M $49.79M
Deferred Revenue (Non-Current) -- -- -- -- $1.47M $2.61M $4.76M $6.00M
Other Non-Current Liabilities -- -- -- -- -- -- -- $37.50M
Total Non-Current Liabilities $25.13M $26.69M $28.20M $29.66M $32.99M $36.17M $40.33M $43.50M
Total Liabilities $41.94M $43.38M $45.66M $56.20M $68.49M $78.16M $80.54M $93.29M
Total Debt (incl. Leases) $30.51M $32.57M $34.57M $36.50M $38.37M $40.20M $42.00M $43.73M
Common Stock $62K $61K $60K $59K $56K $56K $55K $55K
Retained Earnings -$523.0M -$498.3M -$473.8M -$445.9M -$418.5M -$390.6M -$357.2M -$326.2M
Accumulated Other Comp. Income -$629K -$421K -$263K $32K $7.0K -$221K -$199K -$407K
Total Stockholders' Equity $135.1M $154.4M $173.7M $196.1M $219.8M $243.9M $272.7M $299.8M
Total Equity $135.1M $154.4M $173.7M $196.1M $219.8M $243.9M $272.7M $299.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$119.7M -$65.00M $132.3M -$46.41M -$71.20M $36.74M -$43.60M -$88.29M -$70.70M -$40.19M
Depreciation & Amortization $4.06M $4.73M $4.44M $6.19M $5.17M $3.82M $2.77M $2.12M $1.59M $612K
Stock-Based Compensation $14.79M $14.79M $11.15M $9.34M $11.32M $14.93M $15.64M $15.71M $9.24M $6.31M
Change in Receivables -$257K $78.65M -$80.15M -- -- -- -- -- -- --
Change in Payables $1.02M $2.39M -$962K $1.99M -$60K -$3.44M $2.60M -$282K $470K -$62K
Operating Cash Flow -$132.5M -$15.31M $77.92M -$12.51M -$53.52M -$96.72M $48.67M -$15.89M -$61.35M -$42.48M
Capital Expenditure -$2.60M -$3.52M -$3.26M -$2.49M -$1.61M -$12.10M -$7.72M -$4.30M -$3.98M -$5.03M
Free Cash Flow -$135.1M -$18.83M $74.66M -$15.00M -$55.13M -$108.8M $40.95M -$20.19M -$65.33M -$47.51M
Purchases of Investments -$133.9M -$465.7M -$224.0M -$54.85M -$15.12M -$70.40M -$494.2M -$333.2M -$147.3M -$112.3M
Investing Cash Flow $125.4M -$94.86M -$141.6M -$7.34M $65.91M $113.0M -$90.48M $26.47M -$3.68M $47.72M
Common Stock Issued -- $93.47M -- -- -- -- -- -- $57.99M --
Financing Cash Flow $816K $114.0M $33.65M $1.11M $612K $3.16M $80.99M $4.75M $59.92M $514K
Net Change in Cash -$6.21M $3.85M -$30.08M -$18.74M $12.99M $19.44M $39.18M $15.33M -$5.11M $5.75M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$24.69M -$24.47M -$27.94M -$27.43M -$27.89M -$33.38M -$31.02M -$34.49M
Depreciation & Amortization $836K $908K $932K $1.05M $932K $1.06M $1.01M $1.01M
Stock-Based Compensation $2.60M $2.43M $2.49M $3.52M $3.46M $4.13M $3.67M $3.74M
Change in Receivables -$1.08M -$1.44M $267K $1.43M -$1.51M -$51K -$119K $14.45M
Change in Payables $333K -$1.11M -$2.29M $2.90M $312K -$830K -$1.36M $836K
Operating Cash Flow -$19.67M -$25.84M -$33.42M -$30.26M -$31.05M -$33.26M -$37.90M -$14.53M
Capital Expenditure $0 $0 -$14K -$626K -$207K -$1.10M -$658K -$155K
Free Cash Flow -$19.67M -$25.84M -$33.43M -$30.89M -$31.25M -$34.37M -$38.55M -$14.68M
Purchases of Investments -$7.69M -$27.41M -$43.44M -$12.50M -$6.64M -$37.87M -$76.92M -$131.0M
Investing Cash Flow $29.27M $15.39M $8.10M $47.42M $34.89M $1.93M $41.20M -$27.20M
Common Stock Issued $3.03M $2.63M $3.04M -- -- -- -- $0
Financing Cash Flow $3.03M $2.91M $3.33M $136K $85K $513K $82K $574K
Net Change in Cash $12.64M -$7.54M -$21.99M $17.30M $3.92M -$30.82M $3.39M -$41.16M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -326.6% -104.1% 48.8% -124.3% -196.8% 16.0% -49.5% -1195.6% -709.1% -290.4%
Net Profit Margin -296.5% -81.3% 52.9% -113.4% -190.3% 21.5% -41.8% -1158.8% -697.6% -282.7%
Return on Equity (ROE) -61.1% -21.7% 56.0% -78.6% -74.9% 23.8% -43.8% -190.1% -52.7% -29.6%
Return on Assets (ROA) -47.5% -16.5% 37.7% -29.1% -36.7% 14.0% -12.3% -49.9% -38.3% -21.2%
Current Ratio 7.64x 5.56x 4.96x 1.72x 2.68x 7.39x 4.01x 5.13x 10.81x 12.95x
Quick Ratio 7.67x 6.71x 4.82x 1.64x 2.60x 6.77x 3.70x 4.92x 10.63x 12.64x
Debt to Equity 0.19x 0.15x 0.09x 0.39x 0.46x 0.31x 0.34x -- -- --
Revenue Growth (YoY) -49.5% -68.0% +511.2% +9.3% -78.1% +63.9% +1270.1% -24.8% -28.7% -18.0%
Operating Income Growth (YoY) -- -168.3% -- -- -368.8% -- -- -- -- --
Net Income Growth (YoY) -- -149.1% -- -- -293.8% -- -- -- -- --
EPS Growth (YoY) -- -136.7% -- -- -290.9% -- -- -- -- -117.4%
Operating Cash Flow Growth (YoY) -- -119.6% -- -- -- -298.7% -- -- -- -202.9%
Free Cash Flow Growth (YoY) -- -125.2% -- -- -- -365.7% -- -- -- -218.0%
5Y Revenue / Share Growth -85.1% -52.3% +2345.8% +182.1% +76.7% +11.4% -- -- -- --
10Y Revenue / Share Growth -83.4% -- -- -- -- -- -- -- -- --
5Y Net Income / Share Growth -306.2% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -450.1% -340.1% -349.2% -326.6% -447.7% -289.8% -152.0% -104.1%
Net Profit Margin -416.3% -312.6% -319.6% -296.5% -404.8% -253.5% -126.5% -81.3%
Return on Equity (ROE) -77.4% -69.8% -67.2% -61.1% -57.7% -44.2% -31.1% -21.7%
Return on Assets (ROA) -59.0% -54.5% -53.2% -47.5% -44.0% -33.5% -24.0% -16.5%
Current Ratio 6.81x 7.51x 8.42x 7.64x 6.19x 5.43x 6.10x 5.56x
Quick Ratio 8.10x 9.09x 9.92x 7.67x 6.54x 6.28x 7.38x 6.71x
Debt to Equity 0.23x 0.21x 0.20x 0.19x 0.17x 0.16x 0.15x 0.15x
Revenue Growth (YoY) -70.0% -39.1% -59.9% +144.3% -45.7% -82.4% -66.8% -93.0%
Operating Income Growth (YoY) -- -- -- -- -- -- -- -170.8%
Net Income Growth (YoY) -- -- -- -- -- -- -- -161.2%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -164.5% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -168.1% --
Source: SEC EDGAR CompanyFacts (CIK 0001640266) · from March 31, 2014 Data through September 30, 2026 · synced Nov 20, 2026, 05:48 UTC · Open in terminal